• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于估计四参数希尔模型参数的优化设计。

Optimal design for estimating parameters of the 4-parameter hill model.

作者信息

Khinkis Leonid A, Levasseur Laurence, Faessel Hélène, Greco William R

机构信息

Department of Mathematics and Statistics, Canisius College, Buffalo, NY, U.S.A.;

出版信息

Nonlinearity Biol Toxicol Med. 2003 Jul;1(3):363-77. doi: 10.1080/15401420390249925.

DOI:10.1080/15401420390249925
PMID:19330140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2656127/
Abstract

Many drug concentration-effect relationships are described by nonlinear sigmoid models. The 4-parameter Hill model, which belongs to this class, is commonly used. An experimental design is essential to accurately estimate the parameters of the model. In this report we investigate properties of D-optimal designs. D-optimal designs minimize the volume of the confidence region for the parameter estimates or, equivalently, minimize the determinant of the variance-covariance matrix of the estimated parameters. It is assumed that the variance of the random error is proportional to some power of the response. To generate D-optimal designs one needs to assume the values of the parameters. Even when these preliminary guesses about the parameter values are appreciably different from the true values of the parameters, the D-optimal designs produce satisfactory results. This property of D-optimal designs is called robustness. It can be quantified by using D-efficiency. A five-point design consisting of four D-optimal points and an extra fifth point is introduced with the goals to increase robustness and to better characterize the middle part of the Hill curve. Four-point D-optimal designs are then compared to five-point designs and to log-spread designs, both theoretically and practically with laboratory experiments.D-optimal designs proved themselves to be practical and useful when the true underlying model is known, when good prior knowledge of parameters is available, and when experimental units are dear. The goal of this report is to give the practitioner a better understanding for D-optimal designs as a useful tool for the routine planning of laboratory experiments.

摘要

许多药物浓度-效应关系由非线性S形模型描述。属于此类的四参数希尔模型是常用的。实验设计对于准确估计模型参数至关重要。在本报告中,我们研究D-最优设计的性质。D-最优设计可使参数估计的置信区域体积最小化,或者等效地,使估计参数的方差-协方差矩阵的行列式最小化。假定随机误差的方差与响应的某个幂次成正比。为生成D-最优设计,需要假定参数的值。即使这些关于参数值的初步猜测与参数的真实值有明显差异,D-最优设计仍能产生令人满意的结果。D-最优设计的这一特性称为稳健性。它可以用D-效率来量化。引入了一种由四个D-最优点和一个额外的第五个点组成的五点设计,目的是提高稳健性并更好地表征希尔曲线的中间部分。然后从理论和实验室实验实际操作两方面,将四点D-最优设计与五点设计以及对数分布设计进行比较。当真实的基础模型已知、有良好的参数先验知识且实验单元成本较高时,D-最优设计证明了自身的实用性和有效性。本报告的目的是让从业者更好地理解D-最优设计,将其作为实验室实验常规规划的一种有用工具。

相似文献

1
Optimal design for estimating parameters of the 4-parameter hill model.用于估计四参数希尔模型参数的优化设计。
Nonlinearity Biol Toxicol Med. 2003 Jul;1(3):363-77. doi: 10.1080/15401420390249925.
2
Design of experiments for the precise estimation of dose-response parameters: the Hill equation.用于精确估计剂量反应参数的实验设计:希尔方程
J Theor Biol. 1986 Dec 21;123(4):415-30. doi: 10.1016/s0022-5193(86)80211-9.
3
D-optimal designs for parameter estimation for indirect pharmacodynamic response models.间接药效反应模型的参数估计的 D-最优设计。
J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):523-39. doi: 10.1007/s10928-009-9135-7. Epub 2009 Nov 11.
4
Applications of Monte Carlo Simulation in Modelling of Biochemical Processes蒙特卡罗模拟在生化过程建模中的应用
5
On the combination of c- and D-optimal designs: General approaches and applications in dose-response studies.关于c-最优设计与D-最优设计的组合:剂量反应研究中的通用方法及应用
Biometrics. 2017 Mar;73(1):206-213. doi: 10.1111/biom.12545. Epub 2016 May 24.
6
Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models.评估非线性混合效应模型随机效应参数设计的稳健性。
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):611-616. doi: 10.1007/s10928-017-9552-y. Epub 2017 Oct 24.
7
Discrete design of enzyme kinetic experiments.酶动力学实验的离散设计
Int J Biomed Comput. 1990 Feb;25(1):7-20. doi: 10.1016/0020-7101(90)90057-2.
8
Bayesian design criteria: computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model.贝叶斯设计标准:计算、比较及其在药代动力学和药效学模型中的应用。
J Pharmacokinet Biopharm. 1995 Feb;23(1):101-25. doi: 10.1007/BF02353788.
9
An evaluation of population D-optimal designs via pharmacokinetic simulations.通过药代动力学模拟对群体D-最优设计进行评估。
Ann Biomed Eng. 2003 Jan;31(1):98-111. doi: 10.1114/1.1533074.
10
Comparing experimental designs for benchmark dose calculations for continuous endpoints.比较用于连续终点基准剂量计算的实验设计。
Risk Anal. 2006 Aug;26(4):1031-43. doi: 10.1111/j.1539-6924.2006.00798.x.

引用本文的文献

1
An Overview of Adaptive Designs and Some of Their Challenges, Benefits, and Innovative Applications.适应性设计概述及其面临的一些挑战、益处和创新应用。
J Med Internet Res. 2023 Oct 16;25:e44171. doi: 10.2196/44171.
2
SB365, Saponin D Induces Caspase-Independent Cell Death and Augments the Anticancer Effect of Temozolomide in Glioblastoma Multiforme Cells.SB365,皂角苷 D 诱导非细胞凋亡性细胞死亡,并增强替莫唑胺在多形性胶质母细胞瘤细胞中的抗癌作用。
Molecules. 2019 Sep 5;24(18):3230. doi: 10.3390/molecules24183230.
3
Optimal designs based on the maximum quasi-likelihood estimator.基于最大拟似然估计量的最优设计。
J Stat Plan Inference. 2016 Nov;178:128-139. doi: 10.1016/j.jspi.2016.07.002. Epub 2016 Jul 15.
4
Evaluation of Drug Concentrations Delivered by Microiontophoresis.微电渗析给药药物浓度评估。
Anal Chem. 2016 Jun 21;88(12):6492-9. doi: 10.1021/acs.analchem.6b01211. Epub 2016 May 27.
5
Temporal Data Set Reduction Based on D-Optimality for Quantitative FLIM-FRET Imaging.基于D-最优性的定量荧光寿命成像-荧光共振能量转移成像的时间数据集约简
PLoS One. 2015 Dec 11;10(12):e0144421. doi: 10.1371/journal.pone.0144421. eCollection 2015.
6
Multiple-Objective Optimal Designs for Studying the Dose Response Function and Interesting Dose Levels.用于研究剂量反应函数和感兴趣剂量水平的多目标优化设计
Int J Biostat. 2015 Nov;11(2):253-71. doi: 10.1515/ijb-2015-0044.
7
Quantitative high-throughput screening data analysis: challenges and recent advances.定量高通量筛选数据分析:挑战与最新进展
Drug Discov Today. 2015 Mar;20(3):296-300. doi: 10.1016/j.drudis.2014.10.005. Epub 2014 Oct 23.
8
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.一种用于与疾病相关的体外和体内机制研究的新型慢性淋巴细胞白血病细胞系的特性分析。
PLoS One. 2013 Oct 9;8(10):e76607. doi: 10.1371/journal.pone.0076607. eCollection 2013.
9
Efficiency of immunotoxin cytotoxicity is modulated by the intracellular itinerary.免疫毒素细胞毒性的效率受细胞内途径的调节。
PLoS One. 2012;7(10):e47320. doi: 10.1371/journal.pone.0047320. Epub 2012 Oct 9.
10
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells.耐药性的翻译起始抑制剂雪兰醇是由 ABCB1/P-糖蛋白过表达介导的急性淋巴细胞白血病细胞。
AAPS J. 2011 Sep;13(3):357-64. doi: 10.1208/s12248-011-9276-7. Epub 2011 May 4.

本文引用的文献

1
A comparison of methods for estimating individual pharmacokinetic parameters.个体药代动力学参数估算方法的比较
J Pharmacokinet Biopharm. 1999 Feb;27(1):103-21. doi: 10.1023/a:1020686830135.
2
Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay.体外抗增殖试验统计特征对临床药效学研究的意义。
J Pharmacokinet Biopharm. 1998 Dec;26(6):717-33. doi: 10.1023/a:1020755124451.
3
Stochastic optimization algorithms of a Bayesian design criterion for Bayesian parameter estimation of nonlinear regression models: application in pharmacokinetics.用于非线性回归模型贝叶斯参数估计的贝叶斯设计准则的随机优化算法:在药代动力学中的应用
Math Biosci. 1997 Aug;144(1):45-70. doi: 10.1016/s0025-5564(97)00017-5.
4
Regression analysis, experimental error, and statistical criteria in the design and analysis of experiments for discrimination between rival kinetic models.用于区分竞争动力学模型的实验设计与分析中的回归分析、实验误差和统计标准。
Methods Enzymol. 1982;87:370-90. doi: 10.1016/s0076-6879(82)87023-7.
5
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.理解剂量-效应关系:药代动力学-药效学模型的临床应用
Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002.
6
Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares.几种最小二乘法的药代动力学参数估计:扩展最小二乘法的优越性
J Pharmacokinet Biopharm. 1985 Apr;13(2):185-201. doi: 10.1007/BF01059398.
7
Design of experiments for the precise estimation of dose-response parameters: the Hill equation.用于精确估计剂量反应参数的实验设计:希尔方程
J Theor Biol. 1986 Dec 21;123(4):415-30. doi: 10.1016/s0022-5193(86)80211-9.
8
Fitting heteroscedastic regression models to individual pharmacokinetic data using standard statistical software.使用标准统计软件将异方差回归模型拟合到个体药代动力学数据。
J Pharmacokinet Biopharm. 1989 Oct;17(5):601-14. doi: 10.1007/BF01071352.
9
A program package for simulation and parameter estimation in pharmacokinetic systems.一个用于药代动力学系统模拟和参数估计的程序包。
Comput Programs Biomed. 1979 Mar;9(2):115-34. doi: 10.1016/0010-468x(79)90025-4.